Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2013
10/30/2013CN103373938A 4-ethoxy-1,3-phenylenedimethylene amide compounds as well as preparation methods and applications thereof
10/30/2013CN103372112A Rhizoma alismatis dropping pill and preparation method thereof
10/30/2013CN103372042A Extracting process of notoginseng saponin
10/30/2013CN103372041A Component with anticoagulation and preparation method thereof
10/30/2013CN103372028A Rotary preparation method of colla corii asini
10/30/2013CN103372018A Application of Chukrasone A in preparation of medicines for increasing blood platelets
10/30/2013CN103372002A Application of Chukrasone B in preparation of medicines for increasing red blood cells
10/30/2013CN103372001A Application of Chukrasone B in preparation of medicines for increasing white blood cells
10/30/2013CN103371967A Furosemide injection and preparation process thereof
10/30/2013CN103371425A Beverage for expelling dampness and cold, regulating qi and blood, nourishing intestines and stomach, relieving cough and asthma, eliminating phlegm, preventing miscarriage and enhancing human body resistance
10/30/2013CN103006876B Externally used traditional Chinese medicine pills for treating metrorrhagia
10/30/2013CN102755553B Sinkiang arnebia root-honeysuckle flower-red paeony root-Chinese arborvitae twig soup for treating allergic purpura
10/30/2013CN102626493B Arborvitae leaf-flos sophorae-thistle-cogongrass rhizome decoction for curing peptic ulcer bleeding
10/30/2013CN102525901B Animal codonopsis pilosula polysaccharide oral solution and preparation method thereof
10/30/2013CN102475727B Detection method of external Pianzaihuang preparation
10/30/2013CN102219853B Anti-H5N1 type bird flue virus vicuna VHH heavy chain antibody as well as preparation method and application thereof
10/30/2013CN102188693B Proteoglycan complex
10/30/2013CN101885684B Aromatic acid pro-drug with nitrogen monoxide donor, and preparation method and application thereof
10/30/2013CN101821259B Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in field of blood coagulation
10/30/2013CN101676286B Azaindoles useful as inhibitors of JAK and other protein kinases
10/30/2013CN101229248B Quality standard and test method of hoove pill and detection method
10/29/2013US8569325 Method of treatment with coadministration of aspirin and prasugrel
10/29/2013US8569283 Compounds and compositions as c-Kit kinase inhibitors
10/29/2013US8569260 N-pyrazole A2A receptor agonists
10/29/2013US8569236 Resuscitation fluid
10/29/2013US8569227 Stabilized fibronectin domain compositions, methods and uses
10/29/2013US8568972 Substances causing differentiation
10/29/2013CA2671975C Film-coated preparation having improved stability
10/29/2013CA2606068C Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
10/24/2013WO2013157967A1 The use of dextran derivatives in preventing or treating anemia.
10/24/2013US20130281705 Compounds for the treatment of metabolic disorders
10/24/2013US20130281487 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
10/24/2013US20130281418 Use of hydroxypregnenolone derivatives for enhancing health and physical performance
10/24/2013US20130280303 Bone delivery system having a therapeutic agent
10/23/2013EP2651395A1 Pharmaceutical compositions of selective factor xa inhibitors for oral administration
10/23/2013CN103370068A Treatment of JAK2-mediated conditions
10/23/2013CN103360494A Completely anti-CD20 human monoclonal antibody and application thereof
10/23/2013CN103360408A Novel thienopyridine compounds and use thereof in medicine
10/23/2013CN103360317A Dicyclo-substituted pyrazolone azo derivatives, as well as preparation method and use thereof
10/23/2013CN103356991A Application of pain-relieving and illness-eliminating granule in preparing drugs for curing cerebral thrombosis
10/23/2013CN103356987A Ephedra-containing traditional Chinese medicine and its preparation method
10/23/2013CN103356984A Traditional Chinese medicine composition for preventing and treating female iron deficiency anemia
10/23/2013CN103356979A Nosebleed pill
10/23/2013CN103356960A Decoction for treatment of jaundice
10/23/2013CN103356954A Externally applied traditional Chinese medicine used for treating ascites
10/23/2013CN103356944A Chinese medicine composition for treating anemia
10/23/2013CN103356916A Traditional Chinese medicinal composition for treating retrograde menstruation
10/23/2013CN103356895A Stasis-removing and bleeding-stopping tablets and preparation method thereof
10/23/2013CN103356881A Qi-invigorating and blood-nourishing chewing tablets and preparation method thereof
10/23/2013CN103356827A Cattail pollen adhesive bandage and preparation method thereof
10/23/2013CN103356826A Dieresis granules and preparation method thereof
10/23/2013CN103356817A Formula for treating acute thrombophlebitis
10/23/2013CN103356696A Acidic concentrate for dialysis
10/23/2013CN103356692A Composite antibacterial gel and preparation method thereof
10/23/2013CN103356682A Application of Houttuynoid D in anti-platelet aggregation medicine
10/23/2013CN103356679A Application of Houttuynoid A in preparation of anti-platelet aggregation medicines
10/23/2013CN103356678A Application of Houttuynoid C in anti-platelet aggregation medicines
10/23/2013CN103356648A Application of Chukrasone A in preparing erythrocyte rising medicines
10/23/2013CN103356642A Application of Chukrasone A in leukocyte-increasing medicines
10/23/2013CN103356640A Application of glucocorticoid in preparation of medicine used for treating and alleviating Graves ophthalmopathy
10/23/2013CN103356623A Novel ferrous fumarate and folic acid compound capsule
10/23/2013CN103356598A Application of Chukrasone B in preparing anti-platelet aggregation medicines
10/23/2013CN103356590A Application of Sarcaboside A in thrombocyte-increasing medicines
10/23/2013CN103356583A Application of Sarcaboside A in preparing anti-platelet aggregation medicine
10/23/2013CN103356566A Application of Sarcaboside B in leukocyte-increasing medicines
10/23/2013CN103356562A Application of Sarcaboside B in preparation of medicines for resisting platelet aggregation
10/23/2013CN103356555A Application of Sarcaboside A in erythrocyte-increasing medicines
10/23/2013CN103356525A Application of Sarcaboside B in thrombocyte-increasing medicines
10/23/2013CN103356513A Applications of delta-elemene and derivative thereof in anti-atherosclerosis
10/23/2013CN103356485A Hirudin albumin nanoparticles and preparation method thereof
10/23/2013CN103356476A Method for dissolving flavonoid compounds, carbon glycoside compounds or stilbene compounds and preparation method of injection or injectable powder injection
10/23/2013CN103355679A Making method of chewable tablet with effect of enriching blood
10/23/2013CN103355655A Composition with alimentary anemia improving function and preparation method of composition
10/23/2013CN102872047B Application of Gypensapogenin A in medicament for increasing level of blood platelets
10/23/2013CN102872043B Application of Gypensapogenin B in medicament of increasing level of leukocyte
10/23/2013CN102716341B Traditional Chinese medicinal composition for treating acute peptic ulcer bleeding and preparation method thereof
10/23/2013CN102702092B Eutectic of two curcumin organic medicaments and preparation method thereof
10/23/2013CN102641506B Bivalirudin-polyethylene glycol compound
10/23/2013CN102585258B Gelatin embolism microsphere and preparation method and application thereof
10/23/2013CN102416203B RNA interference blood vessel stent coating material with local antiplatelet effect and local anticoagulation blood vessel stent prepared therefrom
10/23/2013CN101993489B Reversible hirudin
10/23/2013CN101757058B General flavone extract of hollyhock flower, preparation thereof and application
10/23/2013CN101679298B Fused bicyclic heteroaryl derivatives
10/23/2013CN101035594B Food products for diabetics
10/22/2013US8563042 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
10/22/2013US8562968 Use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leukemia
10/22/2013CA2620296C Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
10/22/2013CA2572872C Tissue factor production inhibitor
10/22/2013CA2491718C Process for producing a virus-inactivated thrombin preparation
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2345375C Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
10/17/2013WO2013155347A1 Bruton's tyrosine kinase inhibitors for hematopoietic mobilization
10/17/2013WO2013154570A1 Synthetic mechanical hemostatic composition, method of making and use thereof
10/17/2013WO2013152683A1 Bicycle substituted pyrazoloneazo derivatives and preparation method and use thereof
10/17/2013WO2013152470A1 Ethyl salicylate glycosides compound, synthetic method and application thereof
10/17/2013US20130273042 Treatment of multiple sclerosis
10/17/2013US20130273009 Methods to mobilize progenitor/stem cells
10/17/2013US20130272997 Synthetic mechanical hemostatic composition, method of making and use thereof
10/16/2013EP2649060A2 Process for the preparation of benzimidazole derivatives and its salts
10/16/2013EP2648728A2 Janus kinase 2 (jak2) inhibitor for the treatment of lupus
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 671